FDA Approves Dosing Tiglutik Via Feeding Tube for ALS Patients
The U.S. Food and Drug Administration has agreed to expand Tiglutik, a liquid oral form of riluzole,…
Articles by Patricia Inácio, PhD
ALS Candidate AT-1501 Advances to Phase 2 Studies, Anelixis Therapeutics Announces
Anelixis Therapeutics has completed its Phase 1 clinical trial testing AT-1501, an investigational antibody, in healthy volunteers and eight…
Kadimastem Seeks to Amend Protocol of its Trial Testing ALS Stem Cell Therapy AstroRx
Kadimastem plans to submit an amendment to the protocol of its ongoing Phase 1/2a trial in Israel assessing the…
ProMIS Neurosciences Develops Antibodies Targeting TDP-43 Aggregates, an ALS Hallmark
ProMIS Neurosciences is advancing its program for amyotrophic lateral sclerosis (ALS) by generating antibodies that specifically target the…
New Assistive Technology Kit to Aid Drake University’s Caregiver Learning Labs
Drake University’s Occupational Therapy Doctorate program is adding a new educational resource that will bring available assistive technology…
$5M in Grants to Support Work into Treatments, Biomarkers for ALS and Frontotemporal Degeneration
Target ALS joined with the Association for Frontotemporal Degeneration (AFTD) to announce a $5 million grant initiative to…
Phase 3 Trial of NurOwn Cell Therapy Fully Enrolls 200 Patients, BrainStorm Announces
BrainStorm Cell Therapeutics announced that the Phase 3 clinical trial of its cell therapy candidate NurOwn in 200 amyotrophic…
Potential Treatment of Mitochondria Seen to Delay Neurologic Symptoms in ALS Mouse Model
The experimental treatment SBT-272 delayed the onset of neurological symptoms, lowered levels of a biomarker of nerve damage, and prolonged…
Animal Study Examines Familial ALS Mutations, Disruptions in the ANXA11 Gene
Mutations in the annexin A11 gene (ANXA11), seen in familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia, disrupt the…
Mutations in FUS Gene Affects Growth and Workings of Motor Neuron Axons, Study Shows
Mutations in the FUS gene, one of the most common causes of familial amyotrophic lateral sclerosis (ALS), increase the number of…